Free Trial

XTX Topco Ltd Buys New Holdings in DaVita Inc. (NYSE:DVA)

DaVita logo with Medical background

Key Points

  • XTX Topco Ltd has invested approximately $1.58 million in DaVita Inc., acquiring 10,356 shares in the first quarter.
  • DaVita reported $2.00 earnings per share for the last quarter, exceeding analyst expectations by $0.25, with a revenue of $3.22 billion.
  • Wall Street analysts have mixed ratings for DaVita, with an average rating of "Hold" and a target price of $167.40.
  • Five stocks to consider instead of DaVita.

XTX Topco Ltd acquired a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 10,356 shares of the company's stock, valued at approximately $1,584,000.

Several other large investors have also recently bought and sold shares of DVA. UMB Bank n.a. lifted its stake in shares of DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares during the period. Copia Wealth Management acquired a new position in shares of DaVita in the 4th quarter valued at $30,000. Coppell Advisory Solutions LLC lifted its stake in shares of DaVita by 50.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after purchasing an additional 100 shares during the period. Canada Post Corp Registered Pension Plan acquired a new position in shares of DaVita in the 4th quarter valued at $55,000. Finally, GeoWealth Management LLC lifted its stake in shares of DaVita by 30.6% in the 4th quarter. GeoWealth Management LLC now owns 525 shares of the company's stock valued at $79,000 after purchasing an additional 123 shares during the period. Institutional investors and hedge funds own 90.12% of the company's stock.

Insider Buying and Selling at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares in the company, valued at $3,905,700. This trade represents a 8.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on DVA shares. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. Truist Financial cut their price target on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, DaVita has a consensus rating of "Hold" and an average target price of $167.40.

Check Out Our Latest Analysis on DaVita

DaVita Stock Down 1.4%

DVA stock traded down $1.93 during trading hours on Friday, reaching $138.44. 686,266 shares of the stock were exchanged, compared to its average volume of 672,836. The firm's 50-day moving average is $140.44 and its 200-day moving average is $147.82. The company has a market cap of $10.45 billion, a price-to-earnings ratio of 13.72, a PEG ratio of 0.96 and a beta of 1.09. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. DaVita Inc. has a 12 month low of $131.76 and a 12 month high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. The company had revenue of $3.22 billion during the quarter, compared to analysts' expectations of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. DaVita's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter last year, the company earned $2.26 EPS. On average, equities research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines